Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | Outcomes of limited stage peripheral T-cell lymphoma

Ahmed Ludvigsen Al-Mashhadi • 21 Jun 2020
EHA 2020
Lymphoma T-Cell Lymphoma CHOP

Ahmed Ludvigsen Al-Mashhadi, MD, of the Aalborg University Hospital, Aalborg, Denmark, discusses a study presented by the NORDIC lymphoma group in limited stage peripheral T-cell lymphoma patients after CHOP-like therapy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Related Videos

1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals